Clinical Trial Update: A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy [NA]

View source ↗

Summary

The document notes that a 12-week study evaluating Femarelle for postmenopausal vulvovaginal atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Vaginal Atrophy
• Vulvovaginal Atrophy

Drugs mentioned

• Femarelle

Snippet

Sponsor: Dr. Lila Nachtigall Rapid Medical Research, New York | Conditions: Vulvo Vaginal Atrophy | NA | Status: COMPLETED